5Anttila HIS, Reitamo S, Erkko P, et al. Interleukin - 8 immunoreactivity in the skin of healthy subjects and patients with palmoplanter pustulosis and psoriasis. J Invest Dermatol 1992;98:96- 101.
6Daniela BC, Karin F, Christoph S, et al. A proinflammatory, activity of interlrukin 8 in human skin: Expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 1996; 184:2007.
7Ockenfels HM, Schultewoher T, Ockenfels G, et al. Tile antipsoriatic agent dimethylfuma- rate immnomodulatcs T- cell cvtokine secretion and inhibits cytokines of the psoriatic cytokine netwotk. Br J Dematol 1998; 139:390.
8Diaz- Guerra MJM, Nelaso M, Martin - Sanz P, et al. Evidence for common mechmaisms in the transcriptional contral of type Ⅱ nitric oxide synthetase in isolated heptocytes. Requirement of NF- kappa B activation after stimulation with bacterial cell wall produeion and phorbolesters. J Biol chem 1996;271:30114- 30120.
9Gilliter R, Berger R, Mielke V, et al. Upper kerationcytes of psoriaticskin lesions express high levels of NAP - 1/IL- 8 mRNA in situ.J Invest Dermatol 1991 ;97:73- 79.
